We only have this paper's title and publication details.
Read it at the sourceExperimental analysis reveals MEK inhibition sensitizes pancreatic cancer cells to STING agonism, indicating tumor-cell intrinsic amplification of type I interferon signaling.
Supplementary Resources and Table
No takes yet. Share an insight, caveat, or question.
Ghukasyan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: